Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer
dc.contributor.author | Milagrel, CS | en_US |
dc.contributor.author | Gopinathanl, G | en_US |
dc.contributor.author | Everitt, G | en_US |
dc.contributor.author | Thompson, RG | en_US |
dc.contributor.author | Kulbel, H | en_US |
dc.contributor.author | Zhong, H | en_US |
dc.contributor.author | Hollingsworth, RE | en_US |
dc.contributor.author | Grose, R | en_US |
dc.contributor.author | Bowte, DDL | en_US |
dc.contributor.author | Hochhauserzl, D | en_US |
dc.contributor.author | Balkwilll, FR | en_US |
dc.date.accessioned | 2015-03-30T08:09:11Z | |
dc.date.available | 2015-01-16 | en_US |
dc.date.issued | 2015-04-01 | en_US |
dc.identifier.issn | 0008-5472 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/7203 | |
dc.format.extent | 1255 - 1264 | en_US |
dc.relation.ispartof | CANCER RESEARCH | en_US |
dc.title | Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1158/0008-5472.CAN-14-1801 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000351948900013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 7 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 75 | en_US |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |